Combination Immunotherapy in Prostate Cancer

During the last decade, there has been significant progress in the field of prostate cancer therapeutic treatments based on androgen receptor-axis-targeted therapies, which resulted in improved clinical outcomes [...].

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancers 2022-12, Vol.14 (24), p.6040
Hauptverfasser:	Baxevanis, Constantin N, Goulielmaki, Maria, Gritzapis, Angelos D, Fortis, Sotirios P
Format:	Artikel
Sprache:	eng
Schlagworte:	Androgens Apoptosis Biomarkers Cancer therapies Care and treatment Chemotherapy Clinical outcomes Conflicts of interest Immunotherapy Lymphocytes Metastasis Methods Prostate cancer Vaccines
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!